Your browser is no longer supported. Please, upgrade your browser.
CRY [NYSE]
CryoLife, Inc.
Index- P/E- EPS (ttm)-0.34 Insider Own3.30% Shs Outstand38.74M Perf Week-4.53%
Market Cap1.16B Forward P/E424.63 EPS next Y0.07 Insider Trans-11.26% Shs Float37.50M Perf Month24.89%
Income-13.10M PEG- EPS next Q-0.05 Inst Own85.90% Short Float10.16% Perf Quarter15.09%
Sales257.90M P/S4.51 EPS this Y-172.00% Inst Trans0.63% Short Ratio17.73 Perf Half Y39.73%
Book/sh7.68 P/B3.70 EPS next Y138.90% ROA-1.70% Target Price34.58 Perf Year30.38%
Cash/sh1.38 P/C20.56 EPS next 5Y2.00% ROE-4.20% 52W Range16.13 - 32.34 Perf YTD20.50%
Dividend- P/FCF2909.01 EPS past 5Y-39.00% ROI0.50% 52W High-9.40% Beta1.55
Dividend %- Quick Ratio2.80 Sales past 5Y11.70% Gross Margin66.50% 52W Low81.65% ATR1.31
Employees1200 Current Ratio4.10 Sales Q/Q7.10% Oper. Margin2.00% RSI (14)63.26 Volatility6.05% 4.77%
OptionableYes Debt/Eq1.07 EPS Q/Q54.40% Profit Margin-5.10% Rel Volume0.46 Prev Close28.45
ShortableYes LT Debt/Eq1.06 EarningsApr 29 AMC Payout- Avg Volume214.90K Price29.30
Recom1.30 SMA2012.87% SMA5020.28% SMA20033.29% Volume33,298 Change2.99%
Feb-14-20Downgrade First Analysis Sec Strong Buy → Outperform
Feb-14-20Downgrade Canaccord Genuity Buy → Hold $32 → $29
Jan-29-20Reiterated Needham Buy $30 → $38
Dec-11-19Upgrade Needham Hold → Buy
Oct-22-19Initiated Oppenheimer Outperform $34
Feb-28-19Initiated Needham Hold
Feb-17-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-09-17Initiated Northland Capital Outperform $23.50
Jun-15-16Initiated Lake Street Buy $15
Apr-28-16Downgrade Ladenburg Thalmann Buy → Neutral
Apr-21-16Resumed Piper Jaffray Overweight
Apr-13-16Initiated Canaccord Genuity Buy $14
Aug-06-12Downgrade The Benchmark Company Buy → Hold
Apr-24-12Initiated Ladenburg Thalmann Buy $7.75
Jul-29-11Upgrade The Benchmark Company Hold → Buy $6.50
Apr-29-11Downgrade The Benchmark Company Buy → Hold $7 → $6.50
Jul-23-10Initiated The Benchmark Company Buy $8
Aug-01-08Reiterated Roth Capital Buy $14 → $15
Aug-01-08Reiterated Jesup & Lamont Buy $14 → $16.50
May-15-08Reiterated Roth Capital Buy $12 → $14
May-03-21 08:25AM  
Apr-30-21 11:00AM  
Apr-29-21 06:05PM  
04:05PM  
02:30PM  
Apr-22-21 12:33PM  
Apr-15-21 08:35AM  
Apr-12-21 03:55PM  
Apr-07-21 08:35AM  
Mar-09-21 08:35AM  
Feb-11-21 11:01PM  
06:55PM  
05:08PM  
04:05PM  
02:30PM  
Feb-10-21 10:51AM  
Feb-05-21 02:06AM  
Jan-28-21 08:30AM  
Dec-11-20 08:48PM  
Nov-19-20 08:30AM  
Nov-04-20 07:35PM  
04:05PM  
02:30PM  
Nov-03-20 10:03AM  
Oct-21-20 08:04AM  
Sep-08-20 04:47PM  
Sep-02-20 04:02PM  
Aug-06-20 08:35AM  
Jul-31-20 10:47AM  
Jul-30-20 07:40PM  
04:05PM  
Jul-23-20 12:32PM  
Jul-21-20 05:00PM  
Jun-19-20 07:05AM  
Jun-18-20 03:07PM  
07:14AM  
07:05AM  
Jun-14-20 08:33PM  
May-08-20 01:10AM  
May-01-20 02:31PM  
Apr-23-20 12:32PM  
Apr-16-20 04:05PM  
Apr-02-20 01:00PM  
07:15AM  
Apr-01-20 04:01PM  
Mar-04-20 04:05PM  
Mar-03-20 05:19PM  
Mar-02-20 08:59AM  
Feb-13-20 06:05PM  
04:05PM  
Feb-06-20 12:31PM  
Jan-30-20 08:34AM  
Jan-21-20 06:06AM  
Jan-17-20 12:02PM  
Jan-16-20 08:37AM  
Dec-23-19 08:30AM  
Dec-19-19 08:30AM  
Dec-16-19 06:08AM  
05:59AM  
Dec-02-19 08:02AM  
08:00AM  
Nov-27-19 07:00AM  
Nov-10-19 08:40AM  
Nov-05-19 09:40AM  
Oct-30-19 07:35PM  
04:05PM  
Oct-28-19 05:07PM  
Oct-23-19 10:33AM  
Oct-16-19 04:35PM  
Oct-15-19 08:22AM  
Sep-18-19 08:34AM  
Sep-15-19 10:21AM  
Sep-13-19 09:07AM  
Sep-11-19 04:03PM  
Aug-29-19 08:34AM  
07:00AM  
Aug-16-19 02:28PM  
Aug-05-19 08:47AM  
Aug-03-19 09:25AM  
Aug-02-19 10:48AM  
Jul-31-19 12:24AM  
Jul-30-19 07:45PM  
04:05PM  
02:30PM  
Jul-25-19 08:34AM  
Jul-23-19 10:32AM  
Jul-17-19 08:34AM  
Jul-12-19 01:18PM  
Jun-28-19 06:54PM  
May-06-19 02:43PM  
May-03-19 11:16AM  
Apr-30-19 11:04PM  
05:19PM  
04:05PM  
Apr-23-19 10:32AM  
Apr-17-19 05:05PM  
Apr-03-19 08:30AM  
Mar-26-19 09:36AM  
Mar-05-19 05:00PM  
Feb-20-19 07:27PM  
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holloway Jean FSVP, General CounselMay 06Option Exercise10.246,61867,76893,848May 10 08:28 AM
Horton AmyVP, Chief Accounting OfficerMay 06Option Exercise11.005,73163,04195,013May 10 08:29 AM
Holloway Jean FSVP, General CounselMay 06Sale30.506,618201,84987,230May 10 08:28 AM
Horton AmyVP, Chief Accounting OfficerMay 06Sale30.005,731171,93089,282May 10 08:29 AM
LEE DAVID ASHLEYExecutive VP, COO & CFOMay 05Option Exercise11.0027,242299,662319,927May 07 04:18 PM
Holloway Jean FSVP, General CounselMay 05Option Exercise10.246,61867,76893,848May 07 04:16 PM
Horton AmyVP, Chief Accounting OfficerMay 05Option Exercise11.005,18657,04694,468May 07 04:17 PM
Holloway Jean FSVP, General CounselMay 05Sale29.506,618195,23187,230May 07 04:16 PM
Horton AmyVP, Chief Accounting OfficerMay 05Sale30.005,186155,58089,282May 07 04:17 PM
LEE DAVID ASHLEYExecutive VP, COO & CFOMay 05Sale30.0027,242817,260292,685May 07 04:18 PM
Maier Dennis BVice President, OperationsApr 30Option Exercise21.553,31471,41723,706May 04 04:17 PM
LEE DAVID ASHLEYExecutive VP, COO & CFOApr 30Option Exercise11.006,80074,800299,485May 04 04:08 PM
Mackin James PPresident & CEOApr 30Option Exercise10.1845,734465,572333,647May 04 04:13 PM
Horton AmyVP, Chief Accounting OfficerApr 30Option Exercise11.002,70029,70091,982May 04 04:06 PM
Horton AmyVP, Chief Accounting OfficerApr 30Sale30.002,70081,00089,282May 04 04:06 PM
Mackin James PPresident & CEOApr 30Sale28.0045,7341,280,552304,178May 04 04:13 PM
LEE DAVID ASHLEYExecutive VP, COO & CFOApr 30Sale30.006,800204,000292,685May 04 04:08 PM
Maier Dennis BVice President, OperationsApr 30Sale28.003,861108,10820,392May 04 04:17 PM
Holloway Jean FSVP, General CounselMar 10Sale25.281,69342,79789,912Mar 11 04:20 PM
Horton AmyVP, Chief Accounting OfficerMar 01Sale25.5313,619347,71191,247Mar 02 04:41 PM
Maier Dennis BVice President, OperationsFeb 17Option Exercise21.556,630142,87623,211Feb 19 04:28 PM
Maier Dennis BVice President, OperationsFeb 17Sale24.737,197177,95616,014Feb 19 04:28 PM
Capps Scott BVP, Clinical ResearchDec 15Option Exercise9.9710,00099,700157,006Dec 16 04:27 PM
Capps Scott BVP, Clinical ResearchDec 15Sale21.348,366178,553148,640Dec 16 04:27 PM
Horton AmyVP, Chief Accounting OfficerDec 14Option Exercise9.976,66666,46099,642Dec 16 08:39 AM
McCall Ronald DDirectorDec 14Sale21.794,638101,069128,795Dec 15 04:38 PM
Maier Dennis BVice President, OperationsDec 14Sale21.851,84340,27016,240Dec 15 04:37 PM
LEE DAVID ASHLEYExecutive VP, COO & CFODec 10Option Exercise9.9716,666166,160299,233Dec 14 04:27 PM
LEE DAVID ASHLEYExecutive VP, COO & CFODec 10Sale23.0016,666383,318282,567Dec 14 04:27 PM
Horton AmyVP, Chief Accounting OfficerDec 01Option Exercise9.976,66666,46099,642Dec 02 04:59 PM
Horton AmyVP, Chief Accounting OfficerDec 01Sale20.786,666138,50392,976Dec 02 04:59 PM
Davis John ESenior VP, Global SalesSep 16Buy16.6510,000166,45970,451Sep 17 05:53 PM
Bullock JamesDirectorSep 16Buy16.6310,000166,27334,023Sep 17 05:50 PM
Horton AmyVP, Chief Accounting OfficerMay 28Sale23.813,00071,41599,642May 29 08:06 AM